Results 151 to 160 of about 7,826 (235)

Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study. [PDF]

open access: yesBreast Cancer Res Treat
Tolosa P   +25 more
europepmc   +1 more source

MeTAline: enabling reproducible and scalable metagenomic analyses. [PDF]

open access: yesNAR Genom Bioinform
Khannous-Lleiffe O   +3 more
europepmc   +1 more source

Gut-Derived Uremic Toxins as a Risk Factor for Vascular Damage in Patients with Chronic Kidney Disease. [PDF]

open access: yesInt J Mol Sci
Ruiz Fuentes MC   +6 more
europepmc   +1 more source

Normative Data for Learning and Memory Test (TAMV-I) in Latin American and Spanish Children: An item response theory and linear mixed models approach. [PDF]

open access: yesPLoS One
Fuentes Mendoza EM   +11 more
europepmc   +1 more source

Microsurgery Versus Radiosurgery for Vestibular Schwannoma: Which Approach Yields Better Long-Term Results? [PDF]

open access: yesCureus
Olvera Morales M   +13 more
europepmc   +1 more source

Heteroresistance to amikacin in <i>Klebsiella aerogenes</i> isolates from patients in an intensive care unit in Brazil. [PDF]

open access: yesMicrobiol Spectr
Crispim NR   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy